Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02263963 · ClinicalTrials.gov registry record · Phase 4
The Transversus Abdominis Plane Block: A Prospective Randomized Clinical Trial Using EXPAREL.
A Phase 4 study, sponsored by Corewell Health West.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT02263963: Completed Phase 4 study, sponsored by Corewell Health West.
NCT02263963 is a Phase 4 study that has completed, run by Corewell Health West. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02263963, a Phase 4 study, has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effectiveness of EXPAREL in a transversus abdominis plane block by assessing the demand of postoperative narcotic, length of hospital stay and incidence of postoperative complications.
Primary Outcome
Patient will be evaluate for their post operative pain by nurses using visual analog scale from 0 to 10, zero means no pain, 10 is the worst pain can patient ever experience.
Interventions
- DRUG Exparel
- PROCEDURE TAP Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
What the finished NCT02263963 record still lists
NCT02263963 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT02263963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02263963 about?
NCT02263963 is a clinical study titled "The Transversus Abdominis Plane Block: A Prospective Randomized Clinical Trial Using EXPAREL.". The purpose of the study is to evaluate the effectiveness of EXPAREL in a transversus abdominis plane block by assessing the demand of postoperative narcotic, length of hospital stay and incidence of postoperative complications.
What is the current status of trial NCT02263963?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2013-07. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02263963?
The interventions under investigation include: Exparel (DRUG), TAP Block (PROCEDURE).
Who is sponsoring clinical trial NCT02263963?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02263963's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia